Cancer therapy targeting CHKA, the enzyme responsible for PCho production from choline, causes tumor growth arrest and apoptosis in preclinical models [44], while treatment targeting glycolytic enzymes in combination with chemotherapy has been shown to re-sensitize cancer cells that had become resistant to treatment [43]. This evidence concerns the gene CHKA and neoplasm.